@article{ec1e18da1859467d84d54ec72b9f38af,
title = "What constitutes experience in surgical treatment of valve disease and how important is it?",
author = "Schaff, {Hartzell V.}",
note = "Funding Information: completed and submitted the ICMJE Form for Disclosure of Potential Conflicts of Interest. Dr Harrington reported receiving fees from Amgen, Bayer, Gilead, Merck, MyoKardia, the Medicines Company, and WebMD; receiving grant funding from Astra Zeneca, Bristol-Myers Squibb, CSL Limited, Glaxo SmithKline, Janssen, Merck, Novartis, Portola, Sanofi Aventis, and the Medicines Company; holding equity in Element Science and Scanadu; and holding an unpaid seat on the board of directors of the American Heart Association. No other disclosures are reported.",
year = "2017",
month = dec,
doi = "10.1001/jamacardio.2017.4004",
language = "English (US)",
volume = "2",
pages = "1299--1300",
journal = "JAMA Cardiology",
issn = "2380-6583",
publisher = "American Medical Association",
number = "12",
}